Ilyang Pharmaceutical Co Ltd (007575) — Free Cash Flow Generation Index
Ilyang Pharmaceutical Co Ltd (007575) has a Free Cash Flow Generation Index of -0.47x as of June 2025. Free cash flow of ₩-1.06 Billion represents 0% of operating cash flow (₩2.26 Billion). Explore Ilyang Pharmaceutical Co Ltd (007575) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Ilyang Pharmaceutical Co Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for Ilyang Pharmaceutical Co Ltd across 11 annual periods. For the full cash flow conversion analysis, see Ilyang Pharmaceutical Co Ltd (007575) cash flow conversion.
Annual Free Cash Flow Generation for Ilyang Pharmaceutical Co Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for Ilyang Pharmaceutical Co Ltd. Check Ilyang Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -6.23x | ₩-35.01 Billion | ₩5.61 Billion | ₩40.62 Billion | ▼ -1270.6% |
| 2023 | 0.53x | ₩7.79 Billion | ₩14.62 Billion | ₩6.83 Billion | ▲ +69.6% |
| 2022 | 0.31x | ₩9.40 Billion | ₩29.94 Billion | ₩4.08 Billion | ▼ -53.9% |
| 2021 | 0.68x | ₩45.67 Billion | ₩67.02 Billion | ₩12.91 Billion | ▲ +19.2% |
| 2020 | 0.57x | ₩32.86 Billion | ₩57.48 Billion | ₩10.17 Billion | ▼ -25.6% |
| 2019 | 0.77x | ₩27.81 Billion | ₩36.19 Billion | ₩2.17 Billion | ▲ +36.6% |
| 2018 | 0.56x | ₩12.44 Billion | ₩22.12 Billion | ₩1.55 Billion | ▼ -19.2% |
| 2017 | 0.70x | ₩20.91 Billion | ₩30.03 Billion | ₩3.78 Billion | ▼ -49.6% |
| 2016 | 1.38x | ₩37.29 Billion | ₩26.98 Billion | ₩10.31 Billion | ▼ -1.2% |
| 2015 | 1.40x | ₩56.35 Billion | ₩40.27 Billion | ₩16.07 Billion | ▼ -19.8% |
| 2014 | 1.75x | ₩32.51 Billion | ₩18.63 Billion | ₩13.89 Billion | — |